Clinical Core

临床核心

基本信息

项目摘要

The Clinical Core is the operational hub of the Center. It is integral to collecting the data necessary for satisfying centerwide aims as well as the specific aims of each research module. The Clinical Core also conducts the psychiatric diagnostic evaluations of all members of the nuclear family (N= 775 families) consisting of the proband father, his spouse, and has biological and stepchildren. Step-parents are also diagnostically evaluated. In addition, this Core performs medical and dental examinations of the children and administers the research protocols to each family member, including collection of biological specimens (blood, saliva, skin, urine) for timely distribution to various laboratories. The Clinical Core ensures compliance with the University of Pittsburgh IRB, HIPPA, and NIH regulations. While primarily responsible for operational support of the Center's scientific activities, faculty in this Core are also integrally involved in empirical research. Accordingly, recent publications have focused on diverse topics, including the role of orodental health on SUD development, suicidality, sexual behavior and STD's, mortality, and health and psychiatric comorbidity.
临床核心是该中心的业务枢纽。它对于收集满足中心范围目标以及每个研究模块的具体目标所需的数据是不可或缺的。临床中心还对核心家庭(N= 775个家庭)的所有成员进行精神病诊断评估,核心家庭由先证者父亲、其配偶以及有生物学和继子女的人组成。继父母也进行诊断评估。此外,该中心还对儿童进行医疗和牙科检查,并向每个家庭成员执行研究方案,包括收集生物标本(血液、唾液、皮肤、尿液),及时分发给各实验室。临床核心确保符合匹兹堡大学IRB, HIPPA和NIH法规。虽然主要负责该中心的科学活动的业务支持,教师在这个核心也整体参与实证研究。因此,最近的出版物集中在不同的主题,包括口腔健康的作用SUD的发展,自杀,性行为和性病的,死亡率,健康和精神共病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JACK R CORNELIUS其他文献

JACK R CORNELIUS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JACK R CORNELIUS', 18)}}的其他基金

Double-blind pilot trial of mirtazapine for the treatment of co-occurring AD/MDD
米氮平治疗同时发生的 AD/MDD 的双盲试点试验
  • 批准号:
    8743170
  • 财政年份:
    2013
  • 资助金额:
    $ 54.36万
  • 项目类别:
Double-blind pilot trial of mirtazapine for the treatment of co-occurring AD/MDD
米氮平治疗同时发生的 AD/MDD 的双盲试点试验
  • 批准号:
    8620304
  • 财政年份:
    2013
  • 资助金额:
    $ 54.36万
  • 项目类别:
CLINICAL CORE
临床核心
  • 批准号:
    7618711
  • 财政年份:
    2008
  • 资助金额:
    $ 54.36万
  • 项目类别:
Psychopathology in Pharmacotherapy of AUD/MDD Teens
AUD/MDD 青少年药物治疗中的精神病理学
  • 批准号:
    7174710
  • 财政年份:
    2005
  • 资助金额:
    $ 54.36万
  • 项目类别:
FLUOXETINE-TREATED AUD-MDD TEENS: LONG TERM OUTCOMES
氟西汀治疗的 AUD-MDD 青少年:长期结果
  • 批准号:
    7066113
  • 财政年份:
    2005
  • 资助金额:
    $ 54.36万
  • 项目类别:
FLUOXETINE-TREATED AUD-MDD TEENS: LONG TERM OUTCOMES
氟西汀治疗的 AUD-MDD 青少年:长期结果
  • 批准号:
    7615102
  • 财政年份:
    2005
  • 资助金额:
    $ 54.36万
  • 项目类别:
Psychopathology in Pharmacotherapy of AUD/MDD Teens
AUD/MDD 青少年药物治疗中的精神病理学
  • 批准号:
    7561651
  • 财政年份:
    2005
  • 资助金额:
    $ 54.36万
  • 项目类别:
Psychopathology in Pharmacotherapy of AUD/MDD Teens
AUD/MDD 青少年药物治疗中的精神病理学
  • 批准号:
    6849513
  • 财政年份:
    2005
  • 资助金额:
    $ 54.36万
  • 项目类别:
FLUOXETINE-TREATED AUD-MDD TEENS: LONG TERM OUTCOMES
氟西汀治疗的 AUD-MDD 青少年:长期结果
  • 批准号:
    6916824
  • 财政年份:
    2005
  • 资助金额:
    $ 54.36万
  • 项目类别:
Psychopathology in Pharmacotherapy of AUD/MDD Teens
AUD/MDD 青少年药物治疗中的精神病理学
  • 批准号:
    7014540
  • 财政年份:
    2005
  • 资助金额:
    $ 54.36万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 54.36万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 54.36万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.36万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.36万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 54.36万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.36万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 54.36万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 54.36万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 54.36万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.36万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了